Upregulation of TET Activity with Ascorbic Acid Induces Epigenetic Modulation of Lymphoma Cells
The Ten Eleven Translocation (TET) enzymes have been found to be mutated in both diffuse large B-cell (DLBCL) and peripheral T-cell (PTCL) lymphomas resulting in DNA hypermethylation. Various important tumor suppressor genes, such as SMAD1 (part of TGF- β signaling), are under-expressed due to aberrantly methylated promoters or enhancers. Recent studies in embryonal stem cells showed that ascorbic acid (AA) is a cofactor for TET with a binding site at the catalytic domain, and enhances TET activity.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Niraj Shenoy, Tushar Bhagat, Mary Stenson, Xiaosheng Wu, Amit Verma, Thomas Witzig Source Type: research
More News: Genetics | Leukemia | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells | Study | Translocation | Vitamin C